| Previous Close | 322.22 |
| Open | 322.05 |
| Bid | 0.00 x |
| Ask | 0.00 x |
| Day's Range | 321.85 - 323.19 |
| 52 Week Range | 203.63 - 323.19 |
| Volume | 272,654 |
| Avg. Volume | 907,165 |
| Market Cap | 23.39B |
| Beta | 0.36 |
| PE Ratio (TTM) | 41.00 |
| EPS (TTM) | 7.86 |
| Earnings Date | Jul 24, 2017 - Jul 28, 2017 |
| Dividend & Yield | 1.04 (0.32%) |
| Ex-Dividend Date | 2017-07-20 |
| 1y Target Est | 305.83 |
Zacks•5 days agoIs a Surprise in Store for CR Bard (BCR) in Q2 Earnings?
Growing adoption of the company's flagship Lutonix drug coated-balloon is expected to benefit C.R. Bard's (BCR) performance in the second quarter.
- Zacks•15 days ago
Becton, Dickinson (BDX) Poised on C.R. Bard Acquisition
On Jul 7, we issued an updated research report on Franklin Lakes, NJ-based Becton, Dickinson and Company (BDX).
- GlobeNewswire•last month
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against C. R. Bard, Inc.
WILMINGTON, Del., June 22, 2017-- Rigrodsky & Long, P.A.:. Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of New Jersey ...
